Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)

Name: Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)
Published: 2011
License: Public Domain

iOMEDICO AG · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

biomarker targetedtherapy

metastatic renal cell carcinoma, failure of exactly one prior vegf-targeted therapy, biomarker, everolimus, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)

Related documents